Omegaven®

DRUG4 trials

Sponsors

Mark Puder, Jeffrey Rudolph, Wake Forest University Health Sciences, Karolinska University Hospital

Conditions

COVID-19Gastrointestinal DiseaseParenteral Nutrition Associated Liver DiseaseShort Bowel SyndromeTotal Parenteral Nutrition-induced Cholestasis

Phase 2

Cholestasis Reversal: Efficacy of IV Fish Oil

CompletedNCT00910104

Mark PuderGastrointestinal Disease, Parenteral Nutrition Associated Liver Disease, Short Bowel Syndrome

Start: 2006-08-31End: 2019-01-23Updated: 2024-09-19

Omegaven® in the Treatment of Parenteral Nutrition (PN) Induced Liver Injury

CompletedNCT01845116

Wake Forest University Health SciencesTotal Parenteral Nutrition-induced Cholestasis

Start: 2010-07-31End: 2020-07-31Updated: 2022-11-23

Resolving Inflammatory Storm in COVID-19 Patients by Omega-3 Polyunsaturated Fatty Acids -

CompletedNCT04647604

Karolinska University HospitalCOVID-19

Start: 2020-06-23End: 2021-07-07Updated: 2022-01-05

Unknown Phase

Compassionate Use of Omegaven® in the Treatment of Parenteral Nutrition Associated Hepatic Injury

Jeffrey RudolphTotal Parenteral Nutrition-induced Cholestasis

Updated: 2019-04-24

Related Papers

Fish oil lipid emulsion compared with soybean oil lipid emulsion in pediatric patients with parenteral nutrition‐associated cholestasis: A cost‐effectiveness study

Journal of Parenteral and Enteral Nutrition2024-12-212 citations

Use of Intravenous Soybean and Fish Oil Emulsions in Pediatric Intestinal Failure-Associated Liver Disease: A Multicenter Integrated Analysis Report on Extrahepatic Adverse Events.

2021-10-2310 citations

Stimulating the Resolution of Inflammation Through Omega-3 Polyunsaturated Fatty Acids in COVID-19: Rationale for the <i>COVID-Omega-F</i> Trial.

2021-01-1153 citations

Fish Oil Emulsion Reduces Liver Injury and Liver Transplantation in Children with Intestinal Failure-Associated Liver Disease: A Multicenter Integrated Study.

2020-10-0832 citations

Intravenous Fish Oil Monotherapy as a Source of Calories and Fatty Acids Promotes Age-Appropriate Growth in Pediatric Patients with Intestinal Failure-Associated Liver Disease.

2020-02-1219 citations

Predictors of failure of fish-oil therapy for intestinal failure-associated liver disease in children.

2016-08-1029 citations

Parenteral fish-oil-based lipid emulsion improves fatty acid profiles and lipids in parenteral nutrition-dependent children.

2011-07-2060 citations